![]() |
|
![]() |
|||||||||||||||||||||||||||||||
|
Alcohol
Alert From NIAAA In 1973, Jones and Smith (1) coined the term "fetal alcohol
syndrome" (FAS) to describe a pattern of abnormalities observed in children born
to alcoholic mothers. It was originally postulated that malnutrition might be
responsible for these defects. Criteria for defining FAS were standardized by the Fetal Alcohol Study Group of the Research Society on Alcoholism in 1980 (4), and modifications were proposed in 1989 by Sokol and Clarren (5). The proposed criteria are 1) prenatal and/or postnatal growth retardation (weight and/or length below the 10th percentile); 2) central nervous system involvement, including neurological abnormalities, developmental delays, behavioral dysfunction, intellectual impairment, and skull or brain malformations; and 3) a characteristic face with short palpebral fissures (eye openings), a thin upper lip, and an elongated, flattened midface and philtrum (the groove in the middle of the upper lip). Sokol and Clarren (5) suggested the term "alcohol-related birth defects" (ARBD) to describe anatomic or functional abnormalities attributed to prenatal alcohol exposure. The term "possible fetal alcohol effect(s)" (FAE) indicates that alcohol is being considered as one of the possible causes of a patient's birth defects. In the view of Sokol and Clarren, the frequent use of this term to indicate a birth defect judged milder than FAS is incorrect, although others continue to use it that way (5). Mental HandicapsMental handicaps and hyperactivity are probably the most debilitating aspects of FAS (6), and prenatal alcohol exposure is one of the leading known causes of mental retardation in the Western World (7). Problems with learning, attention, memory, and problem solving are common, along with incoordination, impulsiveness, and speech and hearing impairment (8,6). Deficits in learning skills persist even into adolescence and adulthood (6,9). It is generally accepted that the adverse effects of prenatal alcohol exposure exist along a continuum, with the complete FAS syndrome at one end of the spectrum and incomplete features of FAS, including more subtle cognitive-behavioral deficits, on the other. Thus, infants with suboptimal neurobehavioral responses may later exhibit subtle deficits in such aspects of daily life as judgment, problem solving, and memory (6). Studies of the incidence of FAS are complicated by
methodological problems. Data have been collected in various ways: 1) in the
catchment approach, birth defects are monitored at the time of birth only; 2) in
retrospective studies, children are identified as having FAS at some time after
birth; and 3) in prospective studies, children are followed over time and
assessed at various intervals from birth onward. Catchment data tend to
underestimate FAS incidence because the neonatal period is a difficult time to
detect FAS. Reported CasesCatchment data on the incidence of FAS are derived from the
Birth Defects Monitoring Program of the Centers for Disease Control (CDC) (13).
Based on data from 1,500 hospitals, CDC reported the nationwide incidence of FAS
to be 0.3-0.9 per 10,000 births (excluding Native Americans). In contrast, Abel
and Sokol (10) surveyed 19 published epidemiologic studies worldwide. The
overall rate from all studies was 1.9 cases per 1,000 live births. The average
for retrospective studies surveyed by Abel and Sokol was 2.9 per 1,000, compared
with 1.1 per 1,000 for prospective studies. According to the CDC catchment study, incidences of FAS per
10,000 total births for different ethnic groups were as follows: Asians 0.3,
Hispanics 0.8, whites 0.9, blacks 6.0, and Native Americans 29.9 (13). Because
of differences in study design, the ratios among the various ethnic groups
derived from the CDC catchment data cannot be used to estimate FAS incidence for
different ethnic groups as obtained from prospective and retrospective studies.
Genetic Susceptibility?In the case of blacks, the risk of FAS remains about sevenfold higher than for whites, even after adjustment for the frequency of maternal alcohol intake, occurrence of chronic alcohol problems, and parity (number of children borne) (16). This raises the question of some kind of genetic susceptibility, the nature of which is unknown. Apart from epidemiology, the key questions in FAS research
include, How much alcohol is too much? and, When is the fetus at greatest risk?
The major problem in addressing these questions is the lack of a specific
physiological measure that accurately reflects alcohol consumption. There is no
biological marker currently available to measure alcohol intake, and
self-reports of alcohol consumption may be unreliable, perhaps especially so
during pregnancy (17). While it is apparent that children who meet the criteria for FAS
are born only to those mothers who consume large amounts of alcohol during
pregnancy, studies have reported neurobehavioral deficits and intrauterine
growth retardation in infants born to mothers who reported themselves to be
moderate alcohol consumers during pregnancy (19,20,21). Minimum Threshold Not DefinedIn a prospective study of 359 newborns, Ernhart and colleagues (22) found a trend toward increasing head and facial abnormalities with increasing embryonic alcohol exposure. An effect occurred at even the lowest reported levels of alcohol intake, so that a clear threshold (minimum amount of alcohol to produce an effect) could not be defined (22). Given the range of defects that result from prenatal alcohol
exposure, the search for an overall threshold for fetal risk may be
unreasonable. Instead, each abnormal outcome in brain structure and function and
growth might have its own dose-response relationship (23). Animal research has
shown that different profiles of alcohol-related birth defects are related to
critical periods for specific aspects of fetal development (3). An important strategy for preventing alcohol-related birth defects is the development of better screening techniques to identify women at high risk for heavy alcohol consumption throughout their pregnancy. Currently available laboratory tests for detecting biochemical markers of heavy drinking are not as sensitive as self-report screening instruments, whereas the latter are complicated by denial (12). Abstaining is the KeyA possible way to overcome denial might be to inquire about
past, rather than present, drinking. This is suggested by the results of a study
showing that self-reports of first trimester drinking made at the seventh month
of pregnancy are often higher than those made at the fourth month (26). The
researchers suggested that women may feel safer reporting higher levels of
drinking farther away from the event. Sokol and colleagues (12) developed a simple and brief
questionnaire to help circumvent denial and underreporting of heavy drinking by
pregnant women. The test instrument, referred to as T-ACE, correctly identified
69 percent of the "risk drinkers" (defined as those consuming 1 ounce of
absolute alcohol per day, equivalent to two standard drinks per day) out of a
cohort of 971 pregnant women. Fetal Alcohol Syndrome--A Commentary by From a scientific perspective, the link between moderate drinking and alcohol-related birth defects has not been clearly established. Whether there is a threshold below which alcohol can be consumed without harming the fetus is not known: self-reported data showing a relationship between moderate use and alcohol-related birth defects may often underestimate the true level of drinking. Researchers are working on developing an objective marker for alcohol consumption that will help clarify these questions and assist clinicians in identifying alcohol-abusing patients as a part of routine prenatal care, using, for example, blood samples typically drawn during an initial examination. Clinicians, however, must offer advice to their patients based upon the best available scientific evidence. Although some clinicians believe that recommending total abstention for pregnant women may subject them to unwarranted guilt about drinking small amounts of alcohol, most accept the need for clinical caution. Because we do not know at what point alcohol damage begins, it is prudent to recommend, as I do, that pregnant women abstain from alcohol use pending confirmation of alcohol's role vis-ą-vis fetal development. There is good news in recent evidence that the number of women who consume alcohol during pregnancy is declining. However, it also appears that the rates of alcohol consumption among high-risk populations (pregnant smokers, unmarried women, women under the age of 25, and women with the least amount of education) remain virtually unchanged (28). This points to a need to develop better targeted prevention and education efforts to reach high-risk populations and to identify women at high risk through primary health care and other systems traditionally used by high-risk individuals before and during pregnancy. References (1) JONES, K.L., & Smith, D.W. Recognition of the fetal alcohol syndrome in early infancy. Lancet 2:999-1001, 1973.(2) PHILLIPS, D.K.; Henderson, G.I.; & Schenker, S. Pathogenesis of fetal alcohol syndrome: Overview with emphasis on the possible role of nutrition. Alcohol Health & Research World 13(3):219-227, 1989.(3) RANDALL, C.L. Alcohol as a teratogen: A decade of research in review. Alcohol and Alcoholism Suppl. 1:125-132, 1987.(4) ROSETT, H.L. A clinical perspective of the fetal alcohol syndrome. Alcoholism: Clinical and Experimental Research 4(2):119-122, 1980.(5) SOKOL, R.J., & Clarren, S.K. Guidelines for use of terminology describing the impact of prenatal alcohol on the offspring. Alcoholism: Clinical and Experimental Research 13(4):597-598, 1989.(6) STREISSGUTH, A.P.; Sampson, P.D.; & Barr, H.M. Neurobehavioral dose-response effects of prenatal alcohol exposure in humans from infancy to adulthood. Annals of the New York Academy of Sciences 562:145-158, 1989.(7) ABEL, E.L., & Sokol, R.J. Fetal alcohol syndrome is now leading cause of mental retardation. Lancet 2:1222, 1986.(8) STREISSGUTH, A.P., & LaDue, R.A. Psychological and behavioral effects in children prenatally exposed to alcohol. Alcohol Health & Research World 10(1):6-12, 1985.(9) STREISSGUTH, A.P.; Aase, J.M.; Clarren, S.K.; Randels, S.P.; LaDue, R.A.; & Smith, D.F. Fetal alcohol syndrome in adolescents and adults. Journal of the American Medical Association 265(15):1961-1967, 1991.(10) ABEL, E.L., & Sokol, R.J. Incidence of fetal alcohol syndrome and economic impact of FAS-related anomalies. Drug and Alcohol Dependence 19:51-70, 1987.(11) LITTLE, B.B.; Snell, L.M.; Rosenfeld, C.R.; Gilstrap, L.C.; & Gant, N.F. Failure to recognize fetal alcohol syndrome in newborn infants. American Journal of Diseases of Children 144(10):1142-1146, 1990.(12) SOKOL, R.J.; Martier, S.S.; & Ager, J.W. The T-ACE questions: Practical prenatal detection of risk-drinking. American Journal of Obstetrics and Gynecology 160(4):863-870, 1989.(13) CHAVEZ, G.F.; Cordero, J.F.; & Becerra, J.E. Leading major congenital malformations among minority groups in the United States, 1981-1986. Journal of the American Medical Association 261(2):205-209, 1989.(14) MAY, P.A.; Hymbaugh, K.J.; Aase, J.M.; & Samet, J.M. Epidemiology of fetal alcohol syndrome among American Indians of the Southwest. Social Biology 30(4):374-387, 1983.(15) AASE, J.M. The fetal alcohol syndrome in American Indians: A high risk group. Neurobehavioral Toxicology and Teratology 3(2):153-156, 1981.(16) SOKOL, R.J.; Ager, J.; Martier, S.; Debanne, S.; Ernhart, C.; Kuzma, J.; & Miller, S.I. Significant determinants of susceptibility to alcohol teratogenicity. Annals of the New York Academy of Sciences 477:87-102, 1986.(17) ERNHART, C.B.; Morrow-Tlucak, M.; Sokol, R.J.; & Martier, S. Underreporting of alcohol use in pregnancy. Alcoholism: Clinical and Experimental Research 12(4):506-511, 1988.(18) MORROW-TLUCAK, M.; Ernhart, C.B.; Sokol, R.J.; Martier, S.; & Ager, J. Underreporting of alcohol use in pregnancy: Relationship to alcohol problem history. Alcoholism: Clinical and Experimental Research 13(3):399-401, 1989.(19) LITTLE, R.E.; Asker, R.L.; Sampson, P.D.; & Renwick, J.H. Fetal growth and moderate drinking in early pregnancy. American Journal of Epidemiology 123(2):270-278, 1986.(20) COLES, C.D.; Smith, I.E.; Lancaster, J.S.; & Falek, A. Persistenc e over the first month of neurobehavioral differences in infants exposed to alcohol prenatally. Infant Behavior and Development 10:23-37, 1987.(21) RUSSELL, M. Clinical implications of recent research on the fetal alcohol syndrome. Bulletin of the New York Academy of Medicine 67(3):207-222, 1991.(22) ERNHART, C.B.; Sokol, R.J.; Martier, S.; Moron, P.; Nadler, D.; Ager, J.W.; & Wolf, A. Alcohol teratogenicity in the human: A detailed assessment of specificity, critical period, and threshold. American Journal of Obstetrics and Gynecology 156(1):33-39, 1987.(23) CLARREN, S.K.; Bowden, D.M.; & Astley, S.J. Pregnancy outcomes after weekly oral administration of ethanol during gestation in the pig-tailed macaque (Macaca nemestrina). Teratology 35(3):345-354, 1987.(24) KOTKOSKIE, L.A., & Norton, S. Cerebral cortical morphology and behavior in rats following acute prenatal ethanol exposure. Alcoholism: Clinical and Experimental Research 13(6):776-781, 1989.(25) WEINER, L., & Morse, B.A. FAS: Clinical perspectives and prevention. In: Chasnoff, I.J., ed. Drugs, Alcohol, Pregnancy and Parenting. Boston: Kluwer Academic Publishers, 1989. pp. 127-148.(26) ROBLES, N., & Day, N.L. Recall of alcohol consumption during pregnancy. Journal of Studies on Alcohol 51(5):403-407, 1990.(27) COLES, C.D.; Smith, I.; Fernhoff, P.M.; & Falek, A. Neonatal neurobehavioral characteristics as correlates of maternal alcohol use during gestation. Alcoholism: Clinical and Experimental Research 9(5):454-460, 1985.(28) SERDULA, M.; Williamson, D.F.; Kendrick, J.S.; Anda, R.F.; & Byers, T. Trends in alcohol consumption by pregnant women: 1985 through 1988. Journal of the American Medical Association 265(7):876-879, 1991.
| ||||||||||||||||||||||||||||||||